OFS资本公司(NASDAQ:OFS)报告称，与上一季度相比，2024年第一季度每股净投资收益增长了20%，达到0.42美元。尽管如此，该公司的每股净资产值(NAV)却出现了下降，主要是由于一些头寸未实现的折旧，尤其是在Pfanstiehl Holdings。本季度的股息分配仍为每股0.34美元。该公司仍对其投资组合充满信心，其投资组合主要由高级担保贷款组成，非常适合当前不确定的宏观经济环境。
OFS Capital宣布，2024年第一季度每股净投资收益为0.42美元，比上一季度增长20%。
该公司的每股NAV下降至11.08美元，主要是由于某些投资的未实现折旧。
一个借贷者，SSJA barariatric，被列为非应计状态，代表一个按公允价值计算，约占投资组合的2%。
OFS Capital的投资组合仍然主要是高级担保贷款，该公司避开了高周期性行业。
企业信贷工具和债务结构定位良好，2026年之前没有债务到期，而且很大一部分是无担保的。
OFS资本保持一个防御性的投资组合定位，重点是资本保值。
该公司预计今年晚些时候并购活动可能会增加，这可能会提供新的投资机会。
OFS资本顾问的经验和长期跟踪记录通过多个信贷周期公司为公司做出贡献驾驭市场的信心。
每股资产净值的下降是一个关键的负面点，主要是由于一项显著的未实现折旧。
缓慢的并购活动影响了新项目，该公司在这一领域仍持谨慎态度。
每股净投资收益的增加是公司盈利能力的一个积极指标。
演示了成功的股权实现，例如TRS Services中的股权实现规划公司创造收益的能力。
该公司的债务结构是固定利率的无担保债务，利率有利，这使其能够很好地抵御市场波动。
利息收入的减少部分是由于整体投资组合的缩小，这是本季度的失误。
投资组合中有息部分的整体投资收益减少了a波1.1%。
在响应回答一个问题关于利息收入恢复的可能性，首席财务官杰夫·切尔尼(Jeff Cerny)表示担心相信公司有能力通过实现股权投资来支付股息将不生息资产转为生息资产。
OFS Capital 2024年第一季度的财务状况喜忧参半，净投资收益上升，每股资产净值下降。该公司谨慎的投资方式，强调优先担保贷款，并回避高周期性行业，反映了其应对不确定经济形势的战略。尽管并购活动放缓，OFS Capital仍积极支持其投资组合公司，并对未来的投资机会持乐观态度。公司稳健的资产负债表和经验丰富的咨询团队为未来的发展奠定了坚实的基础。
OFS Capital Corporation最近的财务表现表明，该公司正以创收和资本保值为战略重点，应对市场挑战。每股净投资收益的上升证明了该公司的盈利能力，尽管它面临着每股资产净值的下降。以下是一些关键的InvestingPro数据和InvestingPro提示，为公司的财务状况和前景提供了进一步的背景:
该公司的市值为127.15亿美元，反映了其在投资领域的规模和市场占有率。
OFS Capital过去12个月的收入增长情况截至2023年第四季度，这一比例为16.82%，显示出强劲的营收增长。然而，它是我值得注意的是，2023年第四季度的收入增长率为-3.68%。
最新数据显示，OFS Capital co .的股息收益率高达14.33%继续向股东回报价值与InvestingPro提示一致，该公司向股东支付了可观的股息。
InvestingPro为OFS Capital提供的投资建议:
1. 该公司已连续12年保持股息支付，这与公司展望中提到的防御性投资组合定位一致。
2. 分析师下调了未来一段时间的收益，以此表示担忧。鉴于该公司最近的财务业绩，投资者可能希望考虑这一点。
对于那些希望深入了解OFS Capital财务指标并获得更多见解的人来说，InvestingPro提供了丰富的信息和技巧。目前，有更多的建议可以帮助投资者做出明智的决定。使用优惠券代码PRONEWS24可以在InvestingPro获得一年或两年一次的Pro和Pro+订阅额外10%的折扣。
接线员:您好，欢迎参加OFS资本公司2024年第一季度收益电话会议。所有参与者都将进入仅听模式。[操作说明]请注意此事件正在被记录。现在我想把会议交给Steve Altebrando，资本市场副总裁。请继续。
Steve Altebrando:大家早上好，感谢大家的到来。今天参加电话会议的还有我们的董事长兼首席执行官Bilal Rashid;Jeff Cerny是该公司的首席财务官兼财务主管。在我们开始之前，请注意，在本次电话会议和网络广播中所作的陈述可能构成适用证券法所定义的前瞻性陈述。这些陈述反映了OFS资本管理公司对预期结果的各种假设、期望和意见，不是对未来业绩的保证，并受到已知和未知风险、不确定性和其他因素的影响，这些因素可能导致实际结果与此类陈述存在重大差异。不确定性和其他因素在某种程度上超出了管理层的控制，包括我们向美国证券交易委员会提交的文件中不时描述的风险因素。尽管我们认为这些假设是合理的，但这些假设中的任何一个都可能被证明是不准确的，因此，基于这些假设的前瞻性陈述也可能是不正确的。您不应过分依赖这些前瞻性陈述。OFS Capital不承担更新此处所作任何前瞻性陈述的义务，所有前瞻性陈述仅适用于本电话会议之日。说到这里，我将把电话交给董事长兼首席执行官比拉尔·拉希德。
Bilal Rashid:谢谢你，Steve。今天早上早些时候，我们公布了第一季度的业绩。我们第一季度的净投资收益为每股0.42美元，比上一季度增长了20%。这一增加主要是由于某些非经常项目。我们继续支付每股0.34美元的股息。正如我们最近在之前的电话会议中讨论的那样，我们相信投资组合的整体健康状况仍然稳固。本季度我们将一家借款人置于非应计状态，按公允价值计算约占投资组合的2%。我们相信，我们将继续受益于我们的资产负债表定位，我们的大部分债务是固定利率，我们的绝大多数贷款组合是浮动利率。我们第一季度的净资产值从年底的每股12.09美元下降到11.08美元，主要是由于未实现的折旧集中在几个头寸上，最明显的是我们在Pfanstiehl Holdings的股权投资，Jeff将详细描述。注意到这种下跌，我们对我们的投资组合仍然感到满意，并相信它在当前的宏观经济环境中处于有利地位。作为我们长期投资原则的一部分，我们仍然致力于避免高周期性行业。我们相信，我们的投资组合仍然保持良好的多元化和防御性定位，我们最大的行业敞口是制造业、医疗保健、批发贸易和商业服务，按季度末的公允价值计算。我们投资纪律的另一个关键部分是在资本结构上进行更高的投资，以公允价值计算，我们的贷款组合中约有100%投资于第一和第二留置权高级担保贷款。我们相信，在这种不确定的宏观经济环境下，这种头寸将继续使我们受益。就新项目而言，并购活动仍然低迷，不过我们预计，随着利率更加明朗，今年晚些时候的并购活动可能会有所增加。与此同时，我们继续积极支持我们现有的投资组合公司。在我们看来，我们的融资将继续使公司受益。在第一季度末，我们100%的未偿债务将在2026年或更晚到期，70%的未偿债务是无担保的。我们与法国巴黎银行(OTC:BNPQY)的1.5亿美元无追索权优先贷款安排将于2027年6月到期。我们公司的信贷额度很灵活，没有按市值计价的规定。正如我们之前所讨论的，我们在2021年锁定了1.8亿美元的固定利率无担保债务，加权平均票面利率为4.8%，明显低于当前的市场价格。正如我们上次电话中提到的，我们在3月份完全偿还了SBIC公司剩余的3190万美元债务，这些债务将于2025年初到期。当我们在这个市场环境中导航时，我们对我们的顾问的经验充满信心，他们管理着大约40亿美元的贷款和结构性信贷市场，在多个资产类别和行业拥有专业知识，并在多个信贷周期中拥有超过25年的跟踪记录。现在，我将把电话转给我们的首席财务官杰夫·切尔尼，他将向大家介绍本季度的更多细节和情况。
Jeff Cerny: Thanks, Bilal. Good morning, everyone. As Bilal mentioned, we posted net investment income of $0.42 per share for the first quarter, once again, covering our $0.34 per share distribution declared during the quarter. Our current distribution rate represents a 13.7% annualized yield based on the price of our common stock at quarter-end. We also announced that our quarterly distribution for the second quarter will remain at $0.34 per share. Our net asset value per share decreased by approximately $1 to $11.08. As Bilal mentioned, this decline was primarily due to unrealized depreciation concentrated in a couple of positions, most notably our equity position in Pfanstiehl Holdings, which declined $7.9 million or $0.59 per share. Pfanstiehl is a manufacturer of specialized products for leading biopharmaceutical firms. We believe its recent decline in value is due to a cyclical downturn in the life sciences industry. However, we remain positive about the long-term outlook for the business. This is a position we invested in more than 10 years ago at a modest cost of only $200,000. To date, we have received approximately $3.4 million in distributions, or approximately 17 times our cost, and as of quarter-end, our fair value is $63.1 million. As you know, we have experience in making these kind of selective equity investments alongside certain of our initial debt investments. This quarter, we had another equity realization in TRS Services for gross proceeds of $3.9 million, recognizing a realized gain of $1.4 million. In addition, we recognized $1.9 million of accumulated preferred dividends from this investment during the quarter. As mentioned, we placed one borrower on non-accrual status during the quarter. SSJA Bariatric, a provider of bariatric surgery and weight management solutions. The sponsor as well as the Founder and CEO have recently contributed meaningful additional capital into the company, which in our view demonstrates their commitment to the business. This loan had a fair value of approximately $8.8 million as of March 31st, representing approximately 2% of the portfolio. Overall, 4.8% of our investments at fair value were on non-accrual status at quarter-end. Turning to the income statement, total investment income was up by approximately 6% to $14.2 million compared to the prior quarter. This was largely due to a non-recurring increase in dividend income, which includes the TRS dividends I just mentioned, offset by a decline in interest income partly due to a smaller overall investment portfolio. This lower overall investment balance is partly related to certain larger prepayments we received in the fourth quarter of 2023, which we utilized to redeem our remaining $31.9 million of SBIC debentures. On March 1st, we completed this redemption, which I previously mentioned was our plan on our prior call. Total expenses of $8.6 million were down approximately 1.7% during the period, primarily due to a decrease in interest expense related to lower average outstanding debt balances during the quarter. As I mentioned, net investment income was $0.42 per share for the first quarter. Net investment income covered our $0.34 distribution for the first quarter, and we believe that net investment income has benefited from our balance sheet positioning given that 91% of our loan portfolio at fair value is floating rate, while approximately 70% of our outstanding debt is fixed rate. It is also worth noting that at quarter-end, all of our outstanding debt matures in 2026 or later, and approximately 70% of our outstanding debt was unsecured. While we have been actively paying down debt over the past few quarters, we have experienced a decline in our regulatory asset coverage ratio due to the unrealized depreciation concentrated in a few positions. In the last quarter, we paid down $43.9 million of debt, including the SBIC debt I mentioned earlier. However, while the SBIC debt contributed to an overall reduction in the balance sheet leverage, this debt was not a component of our regulatory asset coverage requirement. As of quarter-end, our debt-to-equity ratio was approximately 1.74 times and our regulatory asset coverage ratio was 157%. Turning to our investments, we believe the overall performance of our portfolio companies remains solid in this uncertain macroeconomic environment. We are committed to being senior in the capital structure and selective in our underwriting. We remained cautious about new originations and continued to see slow M&A activity during the first quarter. We continue to support our portfolio companies as they identify add-on opportunities for growth, and we also funded a new middle market investment in the first quarter. As of March 31st, we had $10.9 million in commitments to fund investments under various credit facilities to our portfolio companies. The majority of our investments are in loans and approximately 100% of our loan portfolio at fair value was senior secured as of March 31st. based on amortized cost as of quarter-end, our investment portfolio was comprised of approximately 69% senior secured loans, 1% subordinated debt, 24% structured finance securities, and 6% equity securities. At the end of the quarter, we had investments in 74 unique issuers totaling $400.4 million on a fair value basis. The weighted average performing investment income yield on the interest-bearing portion of the portfolio was 13%, which is down about 1.1% quarter-over-quarter. This includes all interest, prepayment fees, and amortization of deferred loan fees. The decline was largely due to the non-accrual loan I mentioned earlier, as well as a slight decrease on the yields earned on our structured finance investments. With that, I'll turn the call back over to Bilal.
Bilal Rashid:谢谢你，Jeff。最后，我们相信我们的投资组合保持良好状态，本季度只有一个新的非应计项目。我们的重点仍然是资本保值，以公允价值计算，我们的贷款组合中约有100%是高级担保的，我们对我们投资组合的整体质量和基本面仍然充满信心。我们一直依靠我们长期的经验和投资纪律，我们相信这对我们很有帮助。自2011年初以来，BDC已投资超过19亿美元，过去13年累计净实现亏损仅为2.5%，同时为我们的投资组合带来了诱人的风险调整后回报。我们相信，由于我们顾问的规模、经验和声誉，我们的业务特别有能力成功地驾驭这个市场。我们的顾问拥有40亿美元的企业信贷平台，隶属于一家300亿美元的资产管理集团，拥有广泛的专业知识，包括长期的银行和资本市场关系。在过去25年多的时间里，我们的企业信贷平台经历了多个信贷周期。我们的顾问和附属公司也与股东紧密合作，因为他们持有公司约23%的股权。说到这里，接线员，请打开电话回答问题。
接线员:现在我们开始问答环节。我们的第一个问题来自奥本海默的米切尔·佩恩。请继续。
米切尔·潘:谢谢。嘿,家伙。一个简短的问题。你们觉得，随着本季度利息收入的下降，你们觉得利息收入还会回升吗?或者你们，你们认为，你们认为有办法弥补股息吗，或者他们会，你们认为会有一些收益来弥补不足吗?
Jeff Cerny:早上好，mitchell。我是杰夫。
米切尔·潘:早上好。
Jeff Cerny:谢谢你的问题。是的，有一条路，绝对有。如你所知，我们在某些股权投资上继续实现盈利，而我们最大的头寸之一是一项无息资产。因此，当然，当我们考虑将其转换为可产生利息的资产时，我们应该能够支付未来的股息。
米切尔·潘:明白了。非常感谢大家。
接线员:我们的问答环节到此结束。会议现在结束了。感谢您参加今天的演讲。您现在可以断开连接。
本文是在人工智能的支持下生成的，并由编辑审阅。欲了解更多信息，请参阅我们的T&C。
